Alan O’connell
Board Of Director
Pharmaceutical Sciences
 Fusion Pharmaceuticals Inc.
Canada
Biography
Dr. O’Connell is a Partner at Seroba. He has a background in product and business development in the pharma/ biotech industry. Prior to joining the firm in 2003, Dr. O’Connell worked in a variety of roles at Elan Corporation (Dublin), American Biogenetic Sciences, Inc. (New York), and he also spent time at the Medicines and Healthcare Products Regulatory Agency (London). His previous venture capital experience was gained at Estée Lauder Investments (New York). Dr. O’Connell still sits on the scientific advisory board of the Lauder funded Alzheimer’s Drug Discovery Foundation. Dr. O’Connell graduated with a Ph.D. (neurophamacology) from the National University of Ireland, Galway (1994) and has a Master’s degree in pharmacology from the University of London (1990). He carried out post-doctoral neuroscience research at University College, Dublin and has published in several scientific journals. Dr. O’Connell also currently sits on the boards of Ario Pharma; Crescent Diagnostics; Heart Metabolics; Opsona Therapeutics; Prexton Therapeutics and Veryan Medical.
Research Interest
Pharmaceutical Sciences
